ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
恩多勒吉克斯
0.2200
0.0000
成交量：
- -
成交額：
- -
市值：
419.19萬
市盈率：
-0.07
高：
0.2200
開：
0.2200
低：
0.2200
收：
0.2200
52周最高：
7.10
52周最低：
0.2200
股本：
1,905.41萬
流通股本：
1,415.05萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-3.1570
每股收益(LYR):
-3.8431
淨資產收益率：
-167.38%
總資產收益率：
-9.82%
市淨率：
0.08
市盈率(LYR):
-0.06
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
恩多勒吉克斯
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.endologix.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
Endologix, Inc.1992年3月成立於加州以心血管動力學公司的名義下.而後於1993年6月在特拉州華州重新合併 。1999年1月，心血管動力學公司（當時一家上市公司）與私人持有的光輝合併醫療系統公司，和公司更名為光芒醫療系統公司2002年5月，合併了那麼私人持股Endologix公司，改變了名字Endologix公司。Endologix公司是與位於加利福尼亞州歐文市的公司總部和生產設施的特拉華州公司。該公司開發，製造，市場，主動脈疾病的治療銷售創新的醫療設備。該產品用於腹主動脈瘤（“AAA”）的治療。在AAA的產品是建立在兩個平台之一：（1）傳統的微創腔內修復（“EVAR”）或（2）密封腔內（“EVAS”），用於密封瘤囊，同時通過保持血流創新的解決方案2血流流明。當前EVAR產品包括Endologix AFX腔內的AAA系統（“AFX”）和Endologix Powerlink上與Intuitrak輸送系統（“Intuitrak”）。目前EVAS產品是Nellix血管瘤密封系統（“Nellix EVAS系統”）。其銷售和EVAR EVAS平台（包括擴展和配件）在美國和歐洲，醫院和第三方國際分銷商在某些歐洲國家和其他地方，提供的報告收入的品牌授權的唯一來源。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ELGX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ELGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELGX\",,,,,undefined,":{"symbol":"ELGX","market":"US","secType":"STK","nameCN":"恩多勒吉克斯","latestPrice":0.22,"timestamp":1594843200000,"preClose":0.22,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":14150504,"shares":19054097,"eps":-3.156966,"marketStatus":"退市","change":0,"latestTime":"07-15 16:00:00 EDT","open":0.22,"high":0.22,"low":0.22,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.156966,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774512000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":835243200000,"exchange":"NASDAQ","adjPreClose":0.22,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELGX\",,,,,undefined,":{"symbol":"ELGX","floatShares":14150504,"roa":"-9.82%","roe":"-167.38%","lyrEps":-3.843145,"shares":19054097,"dividePrice":0,"high":0.22,"amplitude":0,"preClose":0.22,"low":0.22,"week52Low":0.22,"pbRate":"0.08","week52High":7.1,"institutionHeld":0.0956,"latestPrice":0.22,"eps":-3.156966,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.156966,"open":0.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-11","symbol":"ELGX","fiscalQuarterEnding":"2020/03","expectedEps":-0.67,"name":null,"time":"盤後","type":"earning","dateTimestamp":1589169600000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2020-02-19","symbol":"ELGX","fiscalQuarterEnding":"2019/12","expectedEps":-0.7,"name":null,"time":"盤後","type":"earning","dateTimestamp":1582088400000,"reportTimeType":"post","actualEps":-0.42},{"date":"2019-11-06","symbol":"ELGX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.64,"defaultRemindTime":1573074000000,"name":null,"time":"盤後","dateTimestamp":1573016400000,"actualEps":null},{"date":"2019-08-08","symbol":"ELGX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.8,"defaultRemindTime":1565294400000,"name":null,"time":"盤後","dateTimestamp":1565236800000,"actualEps":-1.8},{"market":"US","date":"2019-05-02","symbol":"ELGX","fiscalQuarterEnding":"2019/03","expectedEps":-1.56,"name":null,"time":"盤後","type":"earning","dateTimestamp":1556769600000,"reportTimeType":"post","actualEps":-1.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELGX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELGX","date":"2020-07-14","current":-0.069687,"percent":0.992308,"low":-2.012353,"twenty":-0.914562,"median":-0.401261,"eighty":-0.232945,"high":-0.079323,"avg":-0.608541,"sd":0.50061,"marketCap":5700985},"quantilePoints":[],"updateTime":1774501619347},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.endologix.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Endologix, Inc.1992年3月成立於加州以心血管動力學公司的名義下.而後於1993年6月在特拉州華州重新合併 。1999年1月，心血管動力學公司（當時一家上市公司）與私人持有的光輝合併醫療系統公司，和公司更名為光芒醫療系統公司2002年5月，合併了那麼私人持股Endologix公司，改變了名字Endologix公司。Endologix公司是與位於加利福尼亞州歐文市的公司總部和生產設施的特拉華州公司。該公司開發，製造，市場，主動脈疾病的治療銷售創新的醫療設備。該產品用於腹主動脈瘤（“AAA”）的治療。在AAA的產品是建立在兩個平台之一：（1）傳統的微創腔內修復（“EVAR”）或（2）密封腔內（“EVAS”），用於密封瘤囊，同時通過保持血流創新的解決方案2血流流明。當前EVAR產品包括Endologix AFX腔內的AAA系統（“AFX”）和Endologix Powerlink上與Intuitrak輸送系統（“Intuitrak”）。目前EVAS產品是Nellix血管瘤密封系統（“Nellix EVAS系統”）。其銷售和EVAR EVAS平台（包括擴展和配件）在美國和歐洲，醫院和第三方國際分銷商在某些歐洲國家和其他地方，提供的報告收入的品牌授權的唯一來源。","exchange":"NASDAQ","name":"恩多勒吉克斯","nameEN":"Endologix"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ELGX\",market:\"US\",,,undefined,":null}}